The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
published in: Clinical Cancer Research
date of publication: 2015-01-21
language: English
main subject: blood–brain barrier, temozolomide, glioblastoma
Cites articles 37
- 2013-04-01
- 2012-03-01
Date
Title
Article - wd:Q35463482